Product image of Helituspan Apteo Med (Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M)) supplied by GNH India

Helituspan Apteo Med

Active Ingredient:
Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M)
Origin:
EU

Helituspan Apteo Med (Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M))

Helituspan Apteo Med is a European‑market oral product that contains a dry extract of Hederae folium (ivy leaf) standardized at a 5‑7.5:1 ratio and prepared with 30 % ethanol (m/m) as the extraction solvent. The preparation is supplied in an unspecified dosage form and strength, and it is classified under the broader category of herbal extracts used in various traditional applications and is considered for respiratory or mucosal support in practice.

Manufacturer / TM Owner

Synoptis Pharma Sp Z O O

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Helituspan Apteo Med is generally listed among herbal preparations that contain ivy leaf extract. While specific clinical indications are not established in major regulatory databases, the extract has been traditionally associated with the following uses:

  • Support of normal respiratory function during mild coughs.
  • Adjunctive care for throat irritation.
  • Potential aid in mucous membrane comfort.
  • Use in herbal formulations aimed at promoting expectoration.

Side Effects

Reported adverse effects of ivy leaf dry extract are generally mild, but rare serious reactions have been described.

Common

  • Mild gastrointestinal discomfort (e.g., nausea, abdominal cramps).
  • Transient skin redness or itching at the site of contact.
  • Light‑headedness or mild dizziness.
  • Slight increase in salivation.

Serious

  • Allergic reactions such as urticaria, angioedema, or anaphylaxis.
  • Hepatic enzyme elevation reported in isolated case reports.
  • Severe bronchospasm in individuals with known hypersensitivity to ivy.
  • Persistent vomiting or diarrhea leading to dehydration.

Precautions & Warnings

When considering Helituspan Apteo Med, several precautionary points should be reviewed to ensure safe use.

  • Not recommended for individuals with known hypersensitivity to Hederae folium or related plants.
  • Caution in patients with asthma or chronic obstructive pulmonary disease, as bronchospasm has been reported.
  • Pregnant or breastfeeding persons should consult a healthcare professional before use.
  • Use under medical supervision in children, as safety data are limited.
  • Avoid concurrent use with other herbal cough remedies to prevent additive effects.
  • Monitor liver function in patients with pre‑existing hepatic conditions.

Avoid Interactions

Ivy leaf extract may interact with certain medicines or other herbal products. The following interaction categories are commonly noted.

Avoid

  • Concomitant use with potent bronchodilators may increase risk of bronchospasm.
  • Combination with other mucolytic or expectorant agents without medical guidance.

Use with caution

  • Antihistamines, as additive sedative effects have been reported.
  • Anticoagulant or antiplatelet drugs, due to potential mild platelet inhibition.
  • CYP450‑metabolized drugs, because ethanol solvent may affect metabolism in sensitive individuals.

Frequently Asked Questions

The product contains a dry extract of Hederae folium (ivy leaf) standardized at a 5‑7.5:1 ratio and extracted with 30 % ethanol (m/m).

The regulatory status varies by country; in the EU it is generally marketed as a herbal preparation, but it may not be classified as an OTC drug in all jurisdictions.

It is intended for oral use, although the specific dosage form (e.g., tablet, syrup) is not specified in the available product information.

Ivy leaf extract has traditionally been used to support normal respiratory function and may be considered as an adjunct in mild coughs, but clinical evidence is limited.

Mild gastrointestinal discomfort, transient skin redness or itching, light‑headedness, and increased salivation are among the more frequently reported effects.

Rarely, allergic reactions such as urticaria, angioedema, anaphylaxis, or severe bronchospasm have been reported.

They should consult a healthcare professional before using the product, as safety data for these populations are limited.

Users should avoid the product if they have known hypersensitivity to ivy leaf, exercise caution if they have asthma, and discuss use with a clinician if they have liver disease or are taking other medications.

Potential interactions include additive effects with other bronchodilators, mucolytics, antihistamines, anticoagulants, and possible influence on CYP450‑metabolized drugs.

Additional details may be obtained from the product’s official labeling, the European Medicines Agency database, or a qualified healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT